Practical issues of the use of emollients containing filaggrin modulators in the management of patients with atopic dermatitis and xerosis. (Resolution of the Council of Experts)

Abstract

Leading experts in the field of dermatovenereology, cosmetology, and allergology took part in the meeting of the expert meeting. The working groups of the Meeting of Experts, after discussion, assessed the contribution of filaggrin deficiency to the pathogenesis of atopic dermatitis and other diseases / conditions accompanied by xerosis and formed recommendations for the use of Admer's emollient, taking into account the role of filaggrin in the development of atopic dermatitis and xerosis. The experts comprehensively considered the choice of basic therapy for atopic dermatitis, xerosis of various etiologies, discussed the possibilities of secondary prevention of AD and developed unified recommendations on the principles of managing such patients and the place of emollients in clinical practice. Proposals were made for further educational, informational and organizational activities aimed at expanding the knowledge of patients and doctors on the problem of using emollients in atopic dermatitis and xerosis of various etiologies. This article was first published in the Kremlin Medicine Journal, 2022; N1, p. 4654 [1].